Optimizing treatment for pulmonary edema and heart failure
Official title: Vasodilatation or Loop-Diuretics for Initial Treatment of Pulmonary Congestion Due to Acute Heart Failure - A Randomized Placebo-Controlled Trial
Run by Copenhagen University Hospital, Rigshospitalet · NCT05276219 · Data updated 2026-11-12
This study is testing which treatment works best for people with acute heart failure and pulmonary edema by comparing a diuretic, a vasodilator, and a combination of both.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1041 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 5 sites (Copenhagen, Copenhagen and 4 other locations) |
| Status | Recruiting |
| Started | September 14, 2023 |
| Main results expected | May 1, 2027 |
| Study ends | May 1, 2027 |
| Registry record updated | October 23, 2026 |
| Trial ID | NCT05276219 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who present with acute onset or worsening dyspnea and signs of pulmonary congestion.
✕Probably not a fit
Patients who have received more than 40 mg of IV furosemide within the last three hours or those with ongoing severe arrhythmias may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of three treatment strategies for pulmonary edema in patients experiencing acute heart failure: intravenous loop-diuretics (furosemide), vasodilation (nitrates), and a combination of both. The study will be conducted in a randomized, double-blinded, placebo-controlled manner, with patients receiving treatment within three hours of hospital admission. The primary objective is to determine which strategy provides superior outcomes in the first six hours of treatment. The trial will include patients with signs of congestion and will evaluate their response to the different treatment approaches.
Why it matters
Potential benefit: If successful, this trial could lead to improved treatment protocols for patients suffering from acute pulmonary edema and heart failure.
How similar studies have gone: While the use of loop-diuretics is well-established, this specific comparison of treatment strategies in a hyperacute setting is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. Age ≥ 18 years 2. Acute (within minutes to days) onset or worsening of subjective dyspnea\* 3. Systolic blood pressure ≥100 mmHg 4. Oxygen saturation \<94% or need of oxygen 5. Signs or suspicion of congestion (peripheral edema, rales, and/or clinical suspicion of congestion) \* * by the best assessment from a medical doctor. Inclusion must not wait on x-ray or other measures: patients suspected of pulmonary congestion should be included immediately. Exclusion criteria 1. More than 50 mg IV furosemide within the last three hours before randomization including prehospital treatment. 2. More than 3 hours from hospital-admission to randomization 3. Ongoing ventricular taky- or brady-arrythmias or supraventricular arrhythmias with HR \> 180 or \< 40 bpm. 4. Suspected severe infection or sepsis. Exclusion criteria are purposely liberal, so patients can be included in accordance with everyday clinical practice. However, a safety criterion will be implemented: If blood pressure drops below 90 mmHg in 2 measurements with 5 minutes apart and/or if urine production is below 50 ml after 1 hour, the intervention will be stopped, and patients can receive furosemide and nitrates freely. We purposely chose not to exclude patients with aortic stenosis, since observational studies did not find excess risk of given nitrates to patients with pulmonary edema and aortic stenosis
Where it's running
-
Bispebjerg Hospital
Copenhagen, Copenhagen, Denmark Recruiting -
Herlev University Hospital
Herlev, Denmark Recruiting -
Hvidovre Hospital
Hvidovre, Denmark Recruiting -
Roskilde Hospital
Roskilde, Denmark Recruiting -
Nordsjællands Hospital
Hillerød, Denmark Active not recruiting
Study contacts
- Principal investigator: Johannes Grand, PhD — Hvidovre University Hospital
- Study coordinator: Johannes Grand, MD, Phd, MPH
- Email: johannes.grand@regionh.dk
- Phone: +4535452121
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Community-informed approaches to equitable heart failure care in primary care
This study tests whether engaging patients, caregivers, community health workers, and care teams can help Mayo Clinic develop equity-focused, practical care strategies for adults with congestive heart failure who face social challenges.
-
Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure
This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.
-
Characterizing phenotypes of acute heart failure
This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.
-
Routine versus provisional distal perfusion catheter placement during mechanical circulatory support
This study tests whether placing a distal perfusion catheter routinely or only provisionally improves limb outcomes in patients needing femoral artery support for mechanical circulatory support.
-
Peripheral Venous Pressure–Guided Care in Heart Failure
In people with congestive heart failure, this study tests whether daily peripheral venous pressure measurements, used to guide treatment, can shorten hospital stays and reduce readmissions compared with standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.